Research Paper Volume 15, Issue 6 pp 2066—2081
Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets
Figure 1. Expression of SHCBP1 and its association with pathological stages. (A) The expression of SHCBP1 was analyzed by using TIMER2 in TCGA dataset. (B) SHCBP1 expression in ACC, DLBC, LAML, LGG, OV, SARC, TGCT, THYM and UCS based on TCGA and GTEx dataset. (C) The expression of SHCBP1 protein in breast cancer, GBM, HNSC, LUAD, PAAD and UCEC based on UALCLAN database. (D) The association between SHCBP1 expression and pathological stages in certain cancers of GEPIA database. *P<0.05; **P<0.01; ***P<0.001.